Evidence map›Paper›PMID 34724797›Full record

ArticleJournal of the American Heart Association2021

Untreated Hypertension and Subsequent Incidence of Colorectal Cancer: Analysis of a Nationwide Epidemiological Database.

Hidehiro Kaneko, Yuichiro Yano, Hidetaka Itoh, Kojiro Morita, Hiroyuki Kiriyama, Tatsuya Kamon, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo, Norifumi Takeda and 11 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. The intersection of colorectal cancer and cardiovascular disease: shared mechanisms and clinical implications.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  3. High incidence of colorectal cancer in Japanese individuals with hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Recent updates and perspectives in "Onco-hypertension".Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 4 countries.

Hidehiro KanekoThe Department of Cardiovascular Medicine The University of Tokyo Japan.ORCID 0000-0003-2553-6170
Yuichiro YanoYCU Center for Novel and Exploratory Clinical Trials Yokohama City University Hospital Yokohama Japan.ORCID 0000-0002-2565-7290
Hidetaka ItohThe Department of Cardiovascular Medicine The University of Tokyo Japan.
Kojiro MoritaThe Department of Clinical Epidemiology and Health Economics School of Public Health The University of Tokyo Japan.ORCID 0000-0002-2306-0669
Hiroyuki KiriyamaThe Department of Cardiovascular Medicine The University of Tokyo Japan.
Tatsuya KamonThe Department of Cardiovascular Medicine The University of Tokyo Japan.
Katsuhito FujiuThe Department of Cardiovascular Medicine The University of Tokyo Japan.
Nobuaki MichihataThe Department of Health Services Research The University of Tokyo Japan.ORCID 0000-0003-3091-114X
Taisuke JoThe Department of Health Services Research The University of Tokyo Japan.
Norifumi TakedaThe Department of Cardiovascular Medicine The University of Tokyo Japan.ORCID 0000-0003-4818-3347
Hiroyuki MoritaThe Department of Cardiovascular Medicine The University of Tokyo Japan.
Akira NishiyamaDepartment of Pharmacology Faculty of Medicine Kagawa University Kagawa Japan.ORCID 0000-0001-5971-820X
Koichi NodeDepartment of Cardiovascular Medicine Saga University Saga Japan.ORCID 0000-0002-2534-0939
George BakrisDepartment of Medicine University of Chicago Medicine Chicago IL.ORCID 0000-0003-1183-1267
Katsuyuki MiuraDepartment of Public Health Shiga University of Medical Science Otsu Japan.
Paul MuntnerDepartment of Epidemiology University of Alabama at Birmingham AL.ORCID 0000-0002-4711-5492
Anthony J VieraThe Department of Family Medicine and Community Health Duke University Durham NC.
Suzanne OparilDivision of Cardiovascular Disease Department of Medicine University of Alabama at Birmingham AL.ORCID 0000-0002-7505-2599
Donald M Lloyd-JonesDepartment of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL.ORCID 0000-0003-0847-6110
Hideo YasunagaThe Department of Health Services Research Faculty of Medicine University of Tsukuba Ibaraki Japan.
Issei KomuroThe Department of Cardiovascular Medicine The University of Tokyo Japan.ORCID 0000-0002-0714-7182
The University of Tokyo · JPUniversity of Alabama at Birmingham · USUniversity of Tokyo Health Sciences · JPUniversity of Tsukuba · JPDuke University Health System · USKagawa University · JPNorthwestern University · USSaga University · JPShiga University of Medical Science · JPUniversity of Chicago · USYokohama City University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Studies of the association of hypertension with incident colorectal cancer (CRC) may have been confounded by including individuals taking antihypertensive medication, at high risk for CRC (ie, colorectal polyps and inflammatory bowel disease), or with shared risk factors (eg, obesity and diabetes). We assessed whether adults with untreated hypertension are at higher risk for incident CRC compared with those with normal blood pressure (BP), and whether any association is evident among individuals without obesity or metabolic abnormalities. Methods and Results Analyses were conducted using a nationwide health claims database collected in the JMDC Claims Database between 2005 and 2018 (n=2 220 112; mean age, 44.1±11.0 years; 58.4% men). Participants who were taking antihypertensive medications or had a history of CRC, colorectal polyps, or inflammatory bowel disease were excluded. Each participant was categorized as having normal BP (systolic BP [SBP]<120 mm Hg and diastolic BP [DBP] <80 mm Hg, n=1 164 807), elevated BP (SBP 120-129 mm Hg and DBP <80 mm Hg, n=341 273), stage 1 hypertension (SBP 130-139 mm Hg or DBP 80-89 mm Hg, n=466 298), or stage 2 hypertension (SBP ≥140 mm Hg or DBP ≥90 mm Hg, n=247 734). Over a mean follow-up of 1112±854 days, 6899 incident CRC diagnoses occurred. After multivariable adjustment, compared with normal BP, hazard ratios for incident CRC were 0.93 (95% CI, 0.85-1.01) for elevated BP, 1.07 (95% CI, 0.99-1.15) for stage 1 hypertension, and 1.17 (95% CI, 1.08-1.28) for stage 2 hypertension. The hazard ratios for incident CRC for each 10-mm Hg-higher SBP or DBP were 1.04 (95% CI, 1.02-1.06) and 1.06 (95% CI, 1.03-1.09), respectively. These associations were present among adults who did not have obesity, high waist circumference, diabetes, or dyslipidemia. Conclusions Higher SBP and DBP, and stage 2 hypertension are associated with a higher risk for incident CRC, even among those without shared risk factors for CRC. BP measurement could identify individuals at increased risk for subsequent CRC.

Indexed as

Colonic PolypsColorectal NeoplasmsHypertensionAdultAntihypertensive AgentsBlood PressureFemaleHumansIncidenceInflammatory Bowel DiseasesMaleMiddle AgedObesityAntihypertensive Agentsblood pressurecolorectal cancerepidemiologyhypertensiononco‐hypertension

Identifiers

PMID34724797
PMCPMC8751953
OpenAlexW3210285763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.